Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Pharaoh Neuro has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Pharaoh Neuro's investors include Hatteras Venture Partners, Arboretum Ventures, IAG Capital Partners, Laerdal Million Lives Fund.
Pharaoh Neuro is headquartered in Minneapolis, United States.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Pharaoh Neuro is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pharaoh Neuro — Funding & Investors." VCBacked, February 18, 2026, https://www.vcbacked.co/company/pharaoh-neuro. Accessed August 14, 2026.
VCBacked. (2026). Pharaoh Neuro — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pharaoh-neuro
{{cite web |title=Pharaoh Neuro — Funding & Investors |url=https://www.vcbacked.co/company/pharaoh-neuro |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated